v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Operating expenses:        
Research and development $ 325 $ 1,000 $ 2,983 $ 4,266
General and administrative 2,633 1,879 7,121 7,602
Total operating expenses 2,958 2,879 10,104 11,868
Loss from operations (2,958) (2,879) (9,921) (11,746)
Other (expense) income:        
Other income 3,556 3,556  
Change in fair value of forward purchase agreement asset (23) (339)  
Change in fair value of SEPA put rights asset (156) (312)
Change in fair value of embedded derivative liability (31) (11)
Gain on extinguishment of accrued liabilities     173
Interest income 18 1 9 63
Interest expense (737) (42) (387) (23)
Total other (expense) income, net (929) 3,515 2,689 40
Net (loss) income (3,887) 636 (7,232) (11,706)
Deemed dividend resulting from the warrant down round     (10,177)  
Net loss attributable to common stockholders (3,887) 312 $ (17,409) $ (11,706)
Loss per share        
Less net income allocated to participating securities 324 [1]    
Net (loss) income allocated to common stock $ (3,887) $ 312    
Net (loss) income per share, basic (in Dollars per share) $ (0.08) $ 0.02 $ (0.74) $ (0.61)
Net (loss) income per share, diluted (in Dollars per share) $ (0.08) $ 0.01 $ (0.74) $ (0.61)
Weighted averages shares outstanding        
Weighted average shares outstanding - basic (in Shares) 50,922,432 19,181,066 23,409,969 19,133,313
Weighted average shares outstanding – diluted (in Shares) 50,922,432 44,549,733 23,409,969 19,133,313
Revenue:        
Total revenues     $ 183 $ 122
Research and development services        
Revenue:        
Total revenues     $ 183  
Collaboration revenue        
Revenue:        
Total revenues       99
Royalty        
Revenue:        
Total revenues       $ 23
[1] Allocated based on the common stock issuable upon conversion of the outstanding preferred stock of 19,887,616 as compared to the sum of common stock outstanding of 19,181,066 and the common stock issuable upon conversion of 19,887,616.